CRY2 and cancer: GEPIA was used to understand the messenger (m)RNA expressions of circadian rhythm-related factors in the PER family (PER1, PER2, and PER3), CRY family (CRY1 and CRY2), BMAL1, and CLOCK in different types of cancer (Figure 1).